REDWOOD CITY, California, January 8 /PRNewswire/ --

Ingenuity Systems, the leading provider of information solutions to help 
life science researchers generate insights from biological and chemical 
information, is pleased to announce that the Pritzker Neuropsychiatric 
Disorders Research Consortium (PNDRC) has renewed and expanded its licensing 
agreement for access to the Ingenuity Pathways Analysis (IPA) software 
application, assisting the PNDRC's efforts to understand neuropsychiatric 
disorders. Consortium members will utilize the newest release of IPA to 
illustrate significant differences in gene expression and to determine 
impact in neuronal pathways, circuits, and target systems.

The PNDRC focuses on the discovery of neurobiological and genetic causes
of severe psychiatric disorders such as major depression, manic-depressive
illness or bipolar disorder, and schizophrenia, with a concerted effort to
identify novel targets for the treatment of these diseases. IPA plays a
significant role in these research programs by enabling the creation and
comprehensive analysis of customized pathways, which can then help correlate
gene expression profiles to functions, diseases, pathways, and molecular
mechanisms in order to better elucidate novel targets.

About Pritzker Neuropsychiatric Disorders Research Consortium (PNDRC)

The PNDRC is a collaborative research enterprise comprised of several
academic institutions including scientific groups at the University of
Michigan, Weill Medical College of Cornell University, Stanford University,
University of California at Irvine, and the University of California at
Davis. The PNDRC is focused on understanding the neurobiology and genetics of
mood disorders and schizophrenia. It is conducting studies on human
post-mortem tissue, blood samples from isolated populations, and various
animal models, to identify altered profiles of gene expression in blood or
brain circuits associated with these disorders. Its aim is to uncover the
causes of these illnesses, identify novel targets for their diagnosis,
treatment and prevention and to ensure that applications of these discoveries
are utilized to the fullest extent possible. More information is available at
http://www.pritzkerneuropsych.org/

About Ingenuity Systems(R)

Ingenuity Systems is a leading provider of information solutions to help
life science researchers generate insights from biological and chemical
information. Ingenuity Systems is recognized as a technology leader,
providing complete solutions for researchers to better understand the complex
systems foundational to human health and disease. Today, Ingenuity's
solutions are used by thousands of researchers at hundreds of leading
pharmaceutical, biotechnology, and academic research institutions worldwide.
Ingenuity was founded in 1998 and is headquartered in Redwood City,
California with offices in Germany, Switzerland, France, the United Kingdom,
and Japan. http://www.ingenuity.com.

Web site: http://www.ingenuity.com
              http://www.pritzkerneuropsych.org